Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.

HOME
>
論文・技術情報
>
Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database.

アブストラクト
ジャーナル名	Therapeutic advances in neurological disorders
Pubmed追加日	2024/9/24
投稿者	Shirani, Afsaneh; Cross, Anne H; Stuve, Olaf
組織名	Department of Neurological Sciences, University of Nebraska Medical Center,;988440 Nebraska Medical Center, Omaha, NE 68198-8440, USA.;Department of Neurology, Washington University School of Medicine, St Louis, MO,;USA.;Department of Neurology, University of Texas Southwestern Medical Center and;Dallas VA Medical Center, Dallas, TX, USA.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/39314262/